GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OSL:NYKD) » Definitions » Change In Other Working Capital

Nykode Therapeutics AS (OSL:NYKD) Change In Other Working Capital : kr-104.11 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Change In Other Working Capital?

Nykode Therapeutics AS's Change In Other Working Capital for the quarter that ended in Jun. 2024 was kr-31.08 Mil. It means Nykode Therapeutics AS's Other Working Capital declined by kr31.08 Mil from Mar. 2024 to Jun. 2024 .

Nykode Therapeutics AS's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was kr-193.01 Mil. It means Nykode Therapeutics AS's Other Working Capital declined by kr193.01 Mil from Dec. 2022 to Dec. 2023 .

Nykode Therapeutics AS Change In Other Working Capital Historical Data

The historical data trend for Nykode Therapeutics AS's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Change In Other Working Capital Chart

Nykode Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial 28.35 122.75 136.30 34.39 -193.01

Nykode Therapeutics AS Quarterly Data
Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -82.23 -26.19 -29.25 -17.58 -31.08

Nykode Therapeutics AS Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-104.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nykode Therapeutics AS Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OSL:NYKD) » Definitions » Change In Other Working Capital
Comparable Companies
OSL:ULTI OSL:AZT OSL:HBC OSL:BGBIO OSL:CIRCA OSL:EXTX OSL:TRMED OSL:LYTIX OSL:ABS OSL:PCIB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
VACBF:USA NYKDo:Sweden 5VB:Germany
Address
Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Website
https://www.nykode.com
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.

Nykode Therapeutics AS Headlines

No Headlines